









Markets
/
Stocks
/
nasdaq-tcrt
/

Alaunos Therapeutics Inc

TCRT

View Detailed Chart

2.740USD

-0.110-3.86%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

4.39MMarket Cap

LossP/E TTM



Alaunos Therapeutics Inc

2.740

-0.110-3.86%

Overview Company Financials

Financials

Intraday

30m

Today

-3.86%

5 Days

-2.42%

1 Month

-45.20%

6 Months

+80.26%

Year to Date

+43.83%

1 Year

-6.48%

View Detailed Chart

Agency Rating

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(9)

Neutral(2)

Buy(1)

Indicators

Sell(4)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.201

Sell

RSI(14)

34.421

Neutral

STOCH(KDJ)(9,3,3)

32.826

Neutral

ATR(14)

0.394

Low Volatility

CCI(14)

-116.774

Sell

Williams %R

83.983

Oversold

TRIX(12,20)

-1.591

Sell

StochRSI(14)

18.031

Sell

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

2.846

Sell

MA10

2.921

Sell

MA20

3.572

Sell

MA50

3.553

Sell

MA100

2.953

Sell

MA200

2.450

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity, oncology and virology.

Ticker SymbolTCRT

CompanyAlaunos Therapeutics Inc

CEOMr. Holger Weis, CPA

Websitehttps://alaunos.com/